polaris: encorafenib/binimetinib for advanced brafv600 melanoma
Published 4 years ago • 434 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
3:19
encorafenib in a combination regimen for braf melanoma
-
0:33
combination encorafenib plus binimetinib in patients with melanoma
-
5:17
dirk schadendorf, esmo 2018 – encorafenib plus binimetinib for braf-mutant metastatic melanoma
-
0:54
beacon encorafenib plus cetuximab with or without binimetinib for braf v600e mutant metastatic
-
4:04
evaluating therapy with encorafenib, binimetinib, and ribociclib in melanoma
-
1:02
dr. flaherty on the tolerability of encorafenib/binimetinib in melanoma
-
2:47
overall survival results for encorafenib plus binimetinib in braf-mutant melanoma
-
4:05
vemurafenib and cobimetinib in patients with braf-mutated melanoma
-
3:02
overall survival update from columbus trial in braf v600-mutant melanoma
-
7:10
columbus: encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with braf-m...
-
6:58
triplet therapies for advanced metastatic melanoma
-
3:08
os rates and prognostic categories for braf-mutated melanoma when treated with combination therapy
-
1:04
the safety of nivolumab for advanced melanoma
-
9:24
anti-pd1 monotherapy or combination with ipi after braf/mek inhibitors in braf-mutant melanoma
-
1:45
dr. ascierto on triplet of encorafenib, binimetinib, and ribociclib in melanoma
-
1:59
trametinib: new treatment for recurrent lgsoc
-
2:26
dr. flaherty on the columbus trial updates in melanoma
-
3:43
the columbus trial in melanoma
-
7:27
polaris: palbociclib for bipoc patients with her2-negative breast cancer